Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: Preliminary report

Journal of Clinical Pathology

Volumn 59, Issue 2, 2006, Pages 150-152

  Nowicki, M ^a   Ostalska Nowicka, D ^a   Miskowiak, B ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; BOMBESIN; CHROMOGRANIN A; ENOLASE; GALANIN; NEUROPEPTIDE Y; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; BONE MARROW METASTASIS; CANCER RELAPSE; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; HEMATOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; NERVE CELL; NERVOUS TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT FAILURE;

ADOLESCENT; BONE MARROW EXAMINATION; BONE MARROW NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOGRANIN A; CHROMOGRANINS; HUMANS; IMMUNOPHENOTYPING; NEOPLASM PROTEINS; NEOPLASM STAGING; NEUROBLASTOMA; NEUROPEPTIDE Y; PROGNOSIS; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 32544449534     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.024687     Document Type: Article

References (15)

1. Leventhal BG. Solid tumors. In: Nelson textbook of pediatrics, 14th ed. Washington: Behrman, 1992:1481-3.
2. Brodeur GM, Maris JM, Yamashiro DJ, et al. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 1997;19:93-101.
3. Nowicki M, Miskowiak B. Comparison of the cell immunophenotype of metastatic and primary foci in stage IV-s neuroblastoma. Folia Histochem Cytobiol 2002;40:297-303.
4. Shi SR, Cote RJ, Taylor CR. Antigen retrieval immunocytochemistry: past, present and future. J Histochem Cytochem 1997;45:327-43.
5. Elias J, Gown A, Nakamura R. Special report: quality control in immunohistochemistry. Am J Clin Pathol 1989;92:836-43.
6. Taupenot L, Harper KL, Mahapatra NR, et al. Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. J Cell Sci 2002;115:4827-41.
7. Halban PA, Irminger JC. Sorting and processing of secretory proteins. Biochem J 1994;299:1-18.
8. Kelly RB. Pathways of protein secretion in eukaryotes. Science 1985;230:25-32.
9. Zukowska-Grojec Z, Wahlestedt C. Origin and actions of neuropeptide Y in the cardiovascular system. In: Colmers WF, Wahlestedt C, eds. The biology of neuropeptide Y and related peptides. Totowa, NJ: Humana Press, 1993:315-88.
10. Zukowska-Grojec Z, Dayao EK, Karwatowska-Prokopczuk E, et al. Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. Am J Physiol 1996;270:H796-800.
11. Lundberg JM, Martinsson A, Hemsen A, et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 1985;133:30-6.
12. Franco-Cereceda A, Owall A, Settergren G, et al. Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery. Cardiovasc Res 1990;24:241-6.
13. Gerald C, Walker MW, Criscione L, et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996;382:168-71.
14. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Fisher TA, et al. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept 1998;25:75-6, 231-8.
15. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 1998;83:187-95.